Drug List Block 2 Reversed Flashcards
Synthetic analog of PGE2
Therapeutic uses:
- Cervical ripening
- Terminating early pregnancy/abortion
Mechanism:
1. Activation of collagenase also relaxing cervical smooth muscle EP4 receptor subtype (for cervical ripening)
- Uterine contractions via EP1/3 receptors
SE:
GI related (nausea, vomiting, diarrhea)
Fever
Uterine rupture: contraindicated in women having history fo cesarean section or other uterine surgery
Dinoprostone
Analog of PGF2alpha
Therapeutic use:
- Termination of pregnancy in 2nd trimester
- Control postpartum hemorrhage that is not responding to conventional treatment methods
Mechanism:
- Stimulates uterine contractility by action at FP receptors
- Postpartum, the drug cause myometrial contractions via FP receptors. This provides hemostasis at the stie of placenta formation
SE: GI related (nausea, vomiting, diarrhea) Fever Uterine rupture (contraindicated in women having history of cesarean section or other uterine surgery) Rare case of bronchoconstrictino
Carboprost
PGE1 analog
Therapeutic use:
Replacement therapy for prevention of ulcers caused by long term NSAIDS
Mechanism:
Suppresses gastric acid secretion by stimulating EP3 receptors on parietal cells; causes decrease in cAMP
Increase mucin and bicarbonate secretion
Increase mucosal blood flow
SE: Diarrhea-common and contraindicated in pregnancy
*(Misoprostol used with methotrexate or mifepristone for termination of early pregnancy)
Misoprostol
PGE1
Use:
- Impotence/ED
- Maintenance of patent ductus arteriosus
Mechanism of action
- Increase in cAMP which relaxes smooth muscle fo corpus cavernosum
- cAMP mediated relaxation of ductus arteriosus smooth muscle
SE:
1. Pain at site of injection (reason for intra-urethral formulation)
Priapism: prolonged erection
2. Apnea in 10% of neonates,
Alprostadil
PGI2 agonist
Therapeutic use: Primary pulmonary hypertension.
Mechanism: cAMP mediated dilation of pulmonary artery vascular smooth muscle
SE: Nausea, vomiting, headache, flushing
Epoprostenol
Prostaglandin PGF2alpha analog
Uses: glaucoma and eyelash hypotrichosis
Mechanism: Increases outflow of aqueous humor and Increases the percent and duration of hairs in the growth phase.
Pharmacology: administered as opthalmic drops
SE: Eye redness, itching, permanent changes in eye color (increased brown pigment), eyelid skin; may increase length and number of eyelashes
Bimatoprost
Mechanism: Blocks 11 beta hydroxylation so synthesis is stopped at 11-desoxycortisol. Does not inhibit ACTH release, so plasma ACTH increases stimulating synthesis and excretion of 17-hydroxycorticoids as 11-desoxycortisol.
Used as a diagnostic test
Metyrapone
Competitive antagonist at progesterone and glucocorticoid receptors
Progesterone antagonist- Termination of pregnancy
Glucocorticoid antagonist- Treat cushing syndrome etc.
Mifepristone
Competitive antagonists at mineralcorticoid receptor
Uses: diuretics, cardiac fibrosis/hypertrophy, HTN
Spironolactone
Competitive antagonists at mineralcorticoid receptor
Uses: diuretics, cardiac fibrosis/hypertrophy, HTN
Eplerenone
Progesterone and Mineralocorticoid and Androgen receptor antagonist
Mineralcorticoid antagonist-diuretic, antagonizes the salt retaining effects of estrogen
Progesterone Agonist- Used with estrogen to suppress ovulation and as hormone replacement therapy in post menopausal women
Androgen receptor antagonist
Drospirenone
Responses: 1. Lymphocytopenia and monocytopenia, Prevent neutrophil adherence to endothelium, Inhibit action of chemotactic factors
2. Interferes with macrophage antigen processing, blocks the actions of lymphokines, inhibits binding to Fc receptors
Toxicity: 1. Suppression of adrenal-pituitary axis (acute adrenal insufficiency on abrupt withdrawal
2. Cushing’s syndrome
Contraindication: in presence of existing infection
Uses: in combination with other drugs in autoimmune diseases and to prevent graft rejection
Prednisolone
Mechanism: Metabolized to 6-mercaptopurine, a purine antimetabolite that inhibits purine biosynthesis thereby inhibitng DNA synthesis, inhibits De novo AND salvage pathways.
Pharmacology: Orally active
Used to inhibit rejection of transplanted organs and some autoimmune diseases such as rheumatoid arthritis
SE: Bone marrow depression, GI and hepatic toxicity
Azathioprine
Mechanism: alkylating agent that cross links DNA to kill replicating and nonreplicating cells.
Pharmacology: Toxic effect more pronounced on B cells so more effective in suppressing humoral immunity.
Orally active.
Use: treatment of autoimmune diseases in combination with other drugs.
NOT EFFECTIVE IN PREVENTING GRAFT REJECTION
SE: Bone marrow depression
Cyclophosphamide
Mechanism: inhibitor of dihydrofolate reductase, inhibits folate dependent steps in purine synthesis, inhibiting DNA synthesis
Use: treat autoimmune diseases
SE: Hepatic toxicity
Methotrexate
Mechanism: Lymphocyte selective immunosuppressant by inhibiting IMP dehydrogenase (necessary for de novo purine synthesis w no effect on salvage pathway). Lymphocytes cannot make GMP via salvage. More selective than AZA or methotrexate but equally effective
Pharmacology: Orally active
Used with cyclosporine and corticosteroids to prevent renal allograft rejection (allowing lower dose of cyclosporine)
Use: treat autoimmune diseases– rheumatoid arthritis and refractory psoriasis
Contraindications: Active GI disease, reduced renal function and infections. Also pregnancy (loss and congenital malformations)
SE: infection, leukopenia, anemia
Mycophenolate Mofetil
Mechanism: binds to cellular receptor Cyclophilin and inhibits calcineurin (a calcium dependent phosphatase), blocking activation of transcription factor NFAT necessary for IL 2 production. Blocks T cell helper function.
Pharmacology: Orally active
Use: Prevent rejection of transplanted organs. some autoimmune diseases. more effective than other agents used with fewer side effects
SE: nephrotoxicity. Hepatotoxicity
Cyclosporine
Mechanism: binds FK binding protein a cyclophilin related protein, same mechanism as cyclosporine. Spectrum is same but 50-100 more potent
SE: less nephro and hepatotoxicity
Tacrolimus
Mechanism: Inhibits T cell activaiton and proliferation downstream of IL-2. Binds FKBP-12, binds and inhibits mTOR (not calcineurin), this mTOR is a kinase involved in cell cycle progression blocking G1->S transition
Use: Same as cyclosporine. Coating of cardiac stents.
Sirolimus
Mechanism: Irreversible inhibitor of cyclooxygenase 1 and 2.
Uses: Cancer? CV disease (low dose) Fever, pain, (intermediate dose) Chronic inflammatory disease/rheumatoid arthritis (high dose)
SE: Typical NSAIDs side effects + Salicylism + Reye’s Syndrome
Pharmacology:
Non COX inhibition effects (1. Uric acid excretion 2. CNS 3. Respiration)
- At low dose decrease uric acid secretion. at high dose increase uric acid excretion.
- CNS (b/c crosses BBB) delirium psychoses, nausea, vomiting.
- Respiration (Direct stim of respiratory center to increase RR, leading to respiratory alkalosis, compensated by a renal excretion of bicarbonate.
- Salicylism
- Reye’s syndrome (liver failure and death related to viral epidemics
Acetylsalicylic Acid/Aspirin
Mechanism: Reversible inhibitor of COX 1 and COX 2. Naproxen has a much longer plasma half life (14 hr vs. 2) than ibuprofen
Uses:
Both: Rheumatoid disorders (including juvenile rheumatoid arthritis), osteoarthritis, mild-to-moderate pain, dysmenorrhea, fever,
Ibuprofen: Inflammatory diseases, IV preparation to induce closure of PDA in premature infants less than 32 wk gestational age when usual treatments ineffective.
Naproxen: manage ankylosing spondylitis, acute gout/bursitis/tendonitis,
SE: Less GI effects than Aspirin
Ibuprofen and Naproxen
Mechanism: Reversible inhibitor of COX 1 and COX 2
Uses:
gout
preterm labor (investigational)
IV form used for closure of patent ductus arteriosus in neonates,
not routinely used to treat pain or fever.
SE: Frequent adverse rxns, CNS severe frontal headache, better tolerated if given at night
Indomethacin
Mechanism: Reversible inhibitor of COX 1 and COX 2
Uses:
Alternative for opioid analgesics in treatment of post-operative pain (short term, and much more effective for pain than inflammation)
SE: Serious adverse effects
Ketorolac
Mechanism: Active metabolite (6methoxy2naphthylacetic acid) is reversible inhibitor of COX2 moreso than COX-1.
Uses:
Osteoarthritis
Rheumatoid arthritis
SE: Well tolerated with less GI effects
Nabumetone